Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Comprehensive Range of Ready-to-Use RNAs

Published: Thursday, February 21, 2013
Last Updated: Wednesday, February 20, 2013
Bookmark and Share
AMSBIO offers customers panels of convenient, ready-to-use RNAs.

AMSBIO has expanded its range of ready-to-use RNA samples to now include mRNA / microRNA tissue preparations and a large number of RNAs from mouse and rat development stages.

With more than 20 years of experience in RNA isolation, AMSBIO has generated over 4000 individual total RNAs ready to go off-the-shelf, many with Bioanalyzer RIN scores to demonstrate their high quality.

Isolated from a variety of tissues - the AMSBIO biorepository of RNA samples covers over 30 species including human, animal, plant, insect and cell line.

Included within the biorepository are a wide range of normal tissue types as well as tissues of human disease conditions, from multiple donors, that are typically difficult to source.

AMSBIO's range of total RNA isolated from major organs (embryonic stages to adult) includes RNA from individual brain regions that are difficult to obtain because of their size and anatomical complexity.

Also available are a comprehensive collection of preparations from placenta, uterus and embryo tissues at different stages of pregnancy plus a complete library of mammary gland specimens from non-pregnant, pregnant, lactating, and involuted animals.

To make purchasing easy for customers - AMSBIO offers customers panels of convenient, ready-to-use RNAs.

Stringent quality control tests are performed on all AMSBIO tissue preparations to confirm the integrity and stability of their RNA.

These purified RNAs are invaluable ready-for-use tools, provided in convenient sizes, for various downstream applications, including microarray hybridization, PCR cDNA synthesis and RT-PCR analysis.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Webinar Discusses DNA Damage in Individual Cells
New on-demand webinar from AMSBIO.
Monday, September 30, 2013
Informative Guide to Gene Silencing & Delivery
AMSBIO’s new guide - 'Top Ten Tips for Gene Silencing & Delivery'.
Tuesday, June 19, 2012
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos